Companies, institutions and data are cited as public industry context. These references do not imply partnership, endorsement, certification or a commercial relationship with our company.
What the source covers
The selected public sources describe industry supply chains. Their scope is separate from the facilities or services available for an individual quotation.
Keep the scope clear
These independent sources do not establish a partnership with BLOPEP, certification of our products or approval of a particular batch. Follow the primary document for details and limitations.
Sources and verification scope
Brazil pharmaceutical imports by partner, HS 30, 2025 ↗
WITS / UN Comtrade
Source details (original language)
- Scope
- Brazilian imports of pharmaceutical products, HS chapter 30
- Document section
- Reporter Brazil, partner China; trade value 1000 USD
- Limitations
- Not peptide-only, not all APIs, and not Bolang sales.
- Claim verification date
- 2026-09-09
Pharmaceutical imports from China, HS 30, 2025 ↗
WITS / UN Comtrade
Source details (original language)
- Scope
- Reported pharmaceutical imports from China, HS chapter 30
- Document section
- United States and European Union rows; trade value 1000 USD
- Limitations
- Do not add EU aggregate to member countries. Not peptide-only trade.
- Claim verification date
- 2026-09-09
Eli Lilly and Company Form 10-K, fiscal year 2025 ↗
SEC · filing by Eli Lilly and Company
Source details (original language)
- Scope
- Lilly reports reliance on China-based suppliers for portions of its supply chain
- Document section
- Manufacturing and supply, p. 21; third-party supply chain risk factors
- Limitations
- Does not identify Bolang, peptide purchases from Bolang, partnership, endorsement or certification.
- Claim verification date
- 2026-09-09
WuXi AppTec expands global manufacturing capacity ↗
WuXi AppTec
Source details (original language)
- Scope
- Corporate statement: >100,000 L at end of 2025; expansion toward 130,000 L
- Document section
- SPPS reactor volume paragraph
- Limitations
- WuXi AppTec capacity only; target is not installed capacity. Not WuXi Biologics or Bolang.
- Claim verification date
- 2026-09-09
Notícias: cooperação e presença global ↗
Chemitex
Source details (original language)
- Scope
- Chemitex reports cooperation with Zhejiang Jiuzhou
- Document section
- Cooperation announcement and Presença Global em 2025
- Limitations
- Self-reported cooperation, not transaction-level customs evidence. Geographic wording was not repeated.
- Claim verification date
- 2026-09-09
Related reading
Chemitex
Company documents and their place in the pharmaceutical supply chain.
Read details →Eli Lilly and Company
Company documents and their place in the pharmaceutical supply chain.
Read details →WuXi AppTec
Company documents and their place in the pharmaceutical supply chain.
Read details →